The Diagnostics and Research Team at bioAffinity Technologies, comprising the Director of Diagnostics, Staff Scientist in Diagnostics, and the VP of Research, develops and optimizes the CyPath diagnostic test in collaboration with the University of Texas Health Science Center. Their work focuses on early-stage cancer detection, ensuring the accuracy, reliability, and advancement of this breakthrough technology.
View all